Researchers at Washington State University have developed a novel surgical implant with the potential to combat staph infections. In laboratory tests, the implant, made using 3D-printing technology, demonstrated an 87% efficacy in killing bacteria responsible for staph infections while maintaining compatibility with surrounding tissues. The implant incorporates 10% tantalum and 3% copper into the traditional titanium alloy, leveraging the antibacterial properties of copper. This innovation aims to address a significant issue in surgeries, where bacterial colonization on implants often leads to complications. The researchers are optimistic about the multifunctional device's ability to control infections and promote bone tissue integration. Future work will focus on enhancing bacterial death rates and ensuring optimal performance under real-world conditions, with a provisional patent filed for this groundbreaking technology.